Regen BioPharma, Inc. announced initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical...
Regen BioPharma, Inc., announced the filing with the United States Patent and Trademark Office of a provisional patent application covering utilization of dendritic cell...
